Brivanib (BMS-540215)

Brivanib is an ATP-competitive inhibitor against VEGFR2 with IC50 of 25 nM, moderate potency against VEGFR-1 and FGFR-1, but >240-fold against PDGFR-β. Phase 3.
Supplier Selleck Chemicals
Product # S1084
Sku # S1084-5mg
Pricing 5mg, $170.00
Feedback